3 Biotech Stocks That Could Double in 2022

Could you get a twofold return in 2022? Some stocks just might give you a good chance at achieving that goal.

We asked three Motley Fool contributors which biotech stocks they think could double in the new year. Here's why they picked Adicet Bio (NASDAQ: ACET), ChemoCentryx (NASDAQ: CCXI), and NRx Pharmaceuticals (NASDAQ: NRXP).

Image source: Getty Images.

Continue reading

Source Fool.com